On April 29, Ge Longhui Biotech (688526.SH) released its first quarter report. Operating revenue was 200 million yuan, down 26.68% year on year, net profit was 87.228 million yuan, down 35.64% year on year, after deducting non-net profit of 76.1578 million yuan, down 40.56% year on year, with basic earnings of 0.18 yuan per share.
科前生物(688526.SH)：一季度净利润8722.8万元 同比下降35.64%
Keqian Biotech (688526.SH): Net profit of 87.228 million yuan in the first quarter decreased 35.64% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.